RxDoctor Payments Data

Dana Petersen, MD

Plastic Surgery within the Head & Neck · San Francisco, CANPI 1568783470

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Stryker at 37.1% of the total.

$1,634in general payments, 2019–2025

Across 46 payments — averaging $35.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$606
  • Smith+Nephew$171
  • Vioptix Inc$152
  • GSK$139
  • Regeneron Healthcare Solutions, Inc.$114
  • Aerin Medical Inc.$92
  • plus $360 from 10 others

What the payments were for

  • Food & beverage$1,634100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,634 in reported general payments places this provider in the 55th percentile of 119 plastic surgery within the head & neck providers in California.

See all plastic surgery within the head & neck providers in California

Medicare billing

Part B allowed, 2024
$144,607
Medicare patients
423
Services billed
1,270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide158$5,721
Azelastine-FluticasoneAzelastine/Fluticasone16$2,448
Fluticasone Propionate113$1,833
Omeprazole106$1,120
Fluocinolone Acetonide Oil24$701
Azelastine Hcl26$492
Acetazolamide13$419
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$276
Montelukast Sodium13$245
Methylprednisolone35$218
Prednisone18$52

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →